AI assistant
Sending…
SILICON LABORATORIES INC. — Director's Dealing 2011
May 19, 2011
31118_dirs_2011-05-19_22ff5813-9d99-42bc-9600-ae1d0d5108ff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SILICON LABORATORIES INC (SLAB)
CIK: 0001038074
Period of Report: 2011-05-17
Reporting Person: SOOCH NAVDEEP S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-05-17 | Common Stock, $0.0001 par value | M | 62334 | $15.1 | Acquired | 681791 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-05-17 | Non-Qualified Stock Option (right to buy) | $15.1 | M | 20834 | Disposed | 2011-09-21 | Common Stock, $0.0001 par value (20834) | Direct |
| 2011-05-17 | Non-Qualified Stock Option (right to buy) | $15.1 | M | 16500 | Disposed | 2011-09-21 | Common Stock, $0.0001 par value (16500) | Direct |
| 2011-05-17 | Non-Qualified Stock Option (right to buy) | $15.1 | M | 25000 | Disposed | 2011-09-21 | Common Stock, $0.0001 par value (25000) | Direct |
Footnotes
F1: Option becomes exercisable as it vests in a series of ten (10) successive equal monthly installments. The first installment will vest on the date exercisable.
F2: Not applicable per instruction 4(c)(iii).
F3: Option is one hundred percent (100%) vested and exercisable on the date of grant.
F4: Option becomes exercisable as it vests in a series of sixty (60) successive equal monthly installments measured from the date of grant. The first installment will vest on the date exercisable.
More from SILICON LABORATORIES INC.
Regulatory Filings
2026
May 28
M&A Activity
2026
May 26
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Mar 25
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 17
Annual Report
2026
Feb 10